Sometimes a study comes along that shows some amazing results and one published in The Lancet does just that.
The study - which looked at people aged between 30 and 85 who were overweight or had obesity - has found a "globally available, low-cost, and safe" diabetes drug called metformin could drastically reduce the instances of long COVID by 40 per cent.
Sadly they didn't find the same results with ivermectin (and they looked).
So what could be going on? How could this old drug be so good at what it's doing? And how could this drug be used to help bring down long COVID cases?
That's on this week's Coronacast - along with a clarification of NSW hospital data and antiviral prescriptions.
Or watch us on YouTube here
Learn more about your ad choices. Visit megaphone.fm/adchoices
The quick, cheap test coming to a stadium near you?
It's not getting worse... but it's also not getting better
All for one, and one for all?
From Sydney to Melbourne...
A dip in numbers! Let's hope it's a trend
The modelling is in. How long might Sydney's lockdown last?
How much worse is it going to get?
Why Sydney's lockdown could grumble along for a while
Why does Sydney need another week?
Sydney's big moment: will lockdown lift?
Create your
podcast in
minutes
It is Free
Newscast
Consider This from NPR
Chasing Life
The Coronavirus Podcast
Up First from NPR